143 related articles for article (PubMed ID: 10332812)
1. Dose-response relationships for hepatic aflatoxin B1-DNA adduct formation in the rat in vivo and in vitro: the use of immunoslot blotting for adduct quantitation.
Phillips JC; Davies S; Lake BG
Teratog Carcinog Mutagen; 1999; 19(2):157-70. PubMed ID: 10332812
[TBL] [Abstract][Full Text] [Related]
2. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns.
Sotomayor RE; Washington M; Nguyen L; Nyang'anyi R; Hinton DM; Chou M
Toxicol Sci; 2003 Jun; 73(2):329-38. PubMed ID: 12700393
[TBL] [Abstract][Full Text] [Related]
3. Liver DNA adducts in methyl-deficient rats administered a single dose of aflatoxin B1.
Mehta R; Laver GW; Stapley R; McMullen E
Carcinogenesis; 1992 Jul; 13(7):1241-7. PubMed ID: 1638693
[TBL] [Abstract][Full Text] [Related]
4. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
Chou MW; Chen W
J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
[TBL] [Abstract][Full Text] [Related]
5. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
6. Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet.
Schrager TF; Newberne PM; Pikul AH; Groopman JD
Carcinogenesis; 1990 Jan; 11(1):177-80. PubMed ID: 2104783
[TBL] [Abstract][Full Text] [Related]
7. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver.
Root M; Lange T; Campbell TC
Chem Biol Interact; 1997 Oct; 106(3):213-27. PubMed ID: 9413548
[TBL] [Abstract][Full Text] [Related]
8. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M
Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377
[TBL] [Abstract][Full Text] [Related]
9. Determination of aflatoxin B1-DNA adduct in rat liver by enzyme immunoassay.
Vidyasagar T; Sujatha N; Sashidhar RB
Analyst; 1997 Jun; 122(6):609-13. PubMed ID: 9282405
[TBL] [Abstract][Full Text] [Related]
10. Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1.
Buss P; Caviezel M; Lutz WK
Carcinogenesis; 1990 Dec; 11(12):2133-5. PubMed ID: 2124951
[TBL] [Abstract][Full Text] [Related]
11. In vivo formation of aflatoxin B1-DNA adducts in parenchymal and non-parenchymal cells of rat liver.
Jennings GS; Oesch F; Steinberg P
Carcinogenesis; 1992 May; 13(5):831-5. PubMed ID: 1586995
[TBL] [Abstract][Full Text] [Related]
12. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aflatoxin B1-DNA binding and adduct formation by selenium in rats.
Shi CY; Chua SC; Lee HP; Ong CN
Cancer Lett; 1994 Jul; 82(2):203-8. PubMed ID: 8050092
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
15. Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver.
Croy RG; Nixon JE; Sinnhuber RO; Wogan GN
Carcinogenesis; 1980; 1(11):903-9. PubMed ID: 11219843
[TBL] [Abstract][Full Text] [Related]
16. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS
Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317
[TBL] [Abstract][Full Text] [Related]
18. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
19. 2-(Allylthio)pyrazine inhibition of aflatoxin B1-induced hepatocarcinogenesis in rats.
Ha TG; Jang JJ; Kim SG; Kim ND
Chem Biol Interact; 1999 Jul; 121(2):209-22. PubMed ID: 10418965
[TBL] [Abstract][Full Text] [Related]
20. Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
Johnson NM; Egner PA; Baxter VK; Sporn MB; Wible RS; Sutter TR; Groopman JD; Kensler TW; Roebuck BD
Cancer Prev Res (Phila); 2014 Jul; 7(7):658-65. PubMed ID: 24662598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
